FDA official logo
GSRS logoPFDA official logo

DOROCUBICEL

UNII:DBD2HM3I4V
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:DOROCUBICEL
GSRS Full Record:

  • ALLOGENEIC HUMAN UMBILICAL CORD BLOOD EXPANDED WITH UM-171
  • Allogeneic human umbilical cord blood derived CD34+ hematopoietic stem and progenitor cells (HSPCs). The CD34+ HSPC fraction is selected from cord blood and expanded ex vivo in serum-free growth medium in the presence of UM171 (trans-N1 -[2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl]cyclohexane-1,4-diamine) dihydrobromide dihydrate and recombinant cytokines such as stem cell factor (SCF), FMS-related tyrosine kinase 3 ligand (Flt3L), thrombopoietin (TPO) and interleukin-6 (IL-6). The expanded fraction predominantly consists of HSPCs (CD34+ CD45RA-cells), with varying levels of dendritic cell progenitors (CD34+ CD86+ cells), mast cell progenitors (Fc epsilon receptor Ia (FCER1A)+ CD117+ cells), and other cell types
  • CORD BLOOD EXPANDED WITH UM-171
  • DOROCUBICEL [USAN]
  • Dorocubicel
  • ECT-001-CB
  • Haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with UM171 ((1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide). The reagent used for MN-172 is known in the literature only under its code - UM171. It is used in manipulation of the hematopoietic cells to enhance their self-renewal. It is recorded as a chemical in databases with the chemical name of: trans-N1-[2-Benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl]cyclohexane-1,4-diamine dihydrobromide dihydrate
  • dorocubicel [INN]



UNII - DBD2HM3I4V | UNII Search Service